Dénia.com
Search

HLA San Carlos organizes a conference on the use of a new test that informs about the risk of suffering from breast cancer

Information
Event Date: February 22th 2019
Event type: Talk / conference
Site: Municipal House of Culture
Schedule: 19: 00 hours
Home: Free
Event finished

HLA San Carlos de Dénia is the first hospital in the Valencian Community that has the Brecanrisk test, a non-invasive technique that would be able to predict a patient's risk of breast cancer. This tool is based on a complex algorithm that uses the genetic information provided by a sample of the patient's blood, breast density from mammography and information about their personal and family history.

"The test could change the way patients perform their breast check and follow-up", says Dr. Begoña Patiño, surgeon specializing in breast cancer and responsible for the Breast Unit of the HLA hospital San Carlos Office from Dénia. According to the specialist, thanks to the existence of this tool, patients have more information about their individual risk, which allows a more personalized follow-up for each patient.

Both the convenience of the test, and the interpretation of the result, should always be carried out under the advice of a breast specialist, who recommends the specific medical guidelines applicable to each patient according to their type of risk and making early diagnosis possible. .

Until now, the BRCA genetic test can detect the existence of a mutation related to a high risk of breast and ovarian cancer. However, although this mutation indicates a high risk of suffering from the disease, its presence is quite infrequent among the population. The criteria for conducting this test were very strict and, in many cases, families with several cases of breast cancer, gave a negative result in this test.

Brecandisk's genetic analysis is based on the knowledge of the existence of up to 120 "mini genetic alterations" (SNPs) that can increase a patient's genetic risk by two to three times and are more frequent in the population.

This new test is especially indicated in healthy women with a family history of breast cancer (one or more cases in the family), high breast density, personal history of precancerous lesions or women with a family history of BRCA negative breast cancer.

The next 22 from February to 19.00 hours Dr. Begoña Patiño will give an informative talk about this new tool in the House of Culture Denia.

About HLA Hospital Group

The HLA Hospital Group is made up of 15 hospitals integrated with 34 multispecialty medical centers and a network of reference units in next-generation treatments. 42 dental clinics, 11 assisted reproduction units, 30 ophthalmological clinics equipped with the most advanced technology and 436 clinical analysis centers complete the structure that HLA makes available to its patients.

With 1300 hospital beds, HLA is a benchmark in hospital and outpatient care. More than 36 years of experience and presence in six countries make up a service model that bases its philosophy on humane treatment, excellence, leadership, responsibility and specialization.

Leave a comment

    37.861
    4.463
    12.913
    2.700